These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 22953628)
1. The Eighth International Congress on Autoimmunity. Vadasz Z; Toubi E Isr Med Assoc J; 2012 Jul; 14(7):459-64. PubMed ID: 22953628 [No Abstract] [Full Text] [Related]
2. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008. Shoenfeld Y; Blank M; Abu-Shakra M; Amital H; Barzilai O; Berkun Y; Bizzaro N; Gilburd B; Zandman-Goddard G; Katz U; Krause I; Langevitz P; Mackay IR; Orbach H; Ram M; Sherer Y; Toubi E; Gershwin ME Isr Med Assoc J; 2008 Jan; 10(1):13-9. PubMed ID: 18300564 [No Abstract] [Full Text] [Related]
3. Immunomodulation with intravenous immunoglobulin. Hall PD Pharmacotherapy; 1993; 13(6):564-73. PubMed ID: 8302679 [TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin and autoimmunity. Zandman-Goddard G Isr Med Assoc J; 2010 Jan; 12(1):45-6. PubMed ID: 20450130 [No Abstract] [Full Text] [Related]
5. Fragments of truth: T-cell targets of polyclonal immunoglobulins in autoimmune diseases. Petta F; De Luca C; Triggiani M; Casolaro V Curr Opin Pharmacol; 2014 Aug; 17():1-11. PubMed ID: 24874003 [TBL] [Abstract][Full Text] [Related]
6. Targeting T regulatory cells in autoimmune diseases. Toubi E Isr Med Assoc J; 2008 Jan; 10(1):73-6. PubMed ID: 18300580 [TBL] [Abstract][Full Text] [Related]
7. Intravenous immunogloblins: myth and reality. Tellier Z Isr Med Assoc J; 2005 Dec; 7(12):762-7. PubMed ID: 16382695 [No Abstract] [Full Text] [Related]
9. The use of immunologic mutations as probes of cellular interactions and autoimmunity in New Zealand mice. Bray KR; Gershwin ME Exp Cell Biol; 1984; 52(1-2):85-96. PubMed ID: 6141962 [No Abstract] [Full Text] [Related]
10. Treatment of autoimmune diseases with intravenous gammaglobulin. Gelfand EW Semin Hematol; 1992 Jul; 29(3 Suppl 2):127-33. PubMed ID: 1387255 [No Abstract] [Full Text] [Related]
11. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. Kazatchkine MD; Kaveri SV N Engl J Med; 2001 Sep; 345(10):747-55. PubMed ID: 11547745 [No Abstract] [Full Text] [Related]
12. Cutaneous immunity and autoimmunity. Alam R Immunol Allergy Clin North Am; 2012 May; 32(2):xi-xii. PubMed ID: 22560147 [No Abstract] [Full Text] [Related]
13. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss. Sapir T; Blank M; Shoenfeld Y Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014 [TBL] [Abstract][Full Text] [Related]
14. [Suppressor T-cells: immunologic regulator cells and clinical perspectives]. Neumann-Haefelin C; Spangenberg HC; Thimme R; Blum HE Dtsch Med Wochenschr; 2004 Jul; 129(30):1627-30. PubMed ID: 15257502 [TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin therapy: the process, the product, the patient, and the pocketbook. Introduction. Harvey RD Pharmacotherapy; 2005 Nov; 25(11 Pt 2):71S-72S. PubMed ID: 16229676 [No Abstract] [Full Text] [Related]
16. [IgM enriched immunoglobulins as a therapy for sepsis and autoimmune diseases]. Yehudai D; Vadasz Z Harefuah; 2012 Mar; 151(3):171-4, 188. PubMed ID: 22519268 [TBL] [Abstract][Full Text] [Related]
17. The geoepidemiology of autoimmunity: capsules from the 7th International Congress on Autoimmunity, Ljubljana, Slovenia, May 2010. Carmi G; Amital H Isr Med Assoc J; 2011 Feb; 13(2):121-7. PubMed ID: 21443044 [No Abstract] [Full Text] [Related]
18. [Molecular studies in autoimmune diseases]. Shirai S Ryumachi; 1994 Apr; 34(2):179-80. PubMed ID: 8202836 [No Abstract] [Full Text] [Related]